Your browser doesn't support javascript.
loading
Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the ß-Confident Registry.
Walker, Ulrich A; Tilson, Hugh H; Hawkins, Philip N; Poll, Tom van der; Noviello, Stephanie; Levy, Jeremy; Vritzali, Eleni; Hoffman, Hal M; Kuemmerle-Deschner, Jasmin B.
Affiliation
  • Walker UA; Department of Rheumatology, University Hospital Basel, Basel, Switzerland ulrich.walker@usb.ch.
  • Tilson HH; Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Hawkins PN; University College London, London, UK.
  • Poll TV; Amsterdam Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Noviello S; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Levy J; Novartis Pharma AG, Basel, Switzerland.
  • Vritzali E; Novartis Pharma AG, Basel, Switzerland.
  • Hoffman HM; University of California San Diego, San Diego, California, USA.
  • Kuemmerle-Deschner JB; Rady Children's Hospital San Diego, San Diego, California, USA.
RMD Open ; 7(2)2021 05.
Article in En | MEDLINE | ID: mdl-34001647
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cryopyrin-Associated Periodic Syndromes Type of study: Guideline / Risk_factors_studies Limits: Adult / Humans Language: En Journal: RMD Open Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cryopyrin-Associated Periodic Syndromes Type of study: Guideline / Risk_factors_studies Limits: Adult / Humans Language: En Journal: RMD Open Year: 2021 Document type: Article Affiliation country: Country of publication: